Compare · GRDN vs YI
GRDN vs YI
Side-by-side comparison of Guardian Pharmacy Services Inc. (GRDN) and 111 Inc. (YI): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both GRDN and YI operate in Retail-Drug Stores and Proprietary Stores (Consumer Staples), so they compete in similar markets.
- GRDN is the larger of the two at $2.51B, about 92.5x YI ($27.2M).
- Over the past year, GRDN is up 58.5% and YI is down 28.9% - GRDN leads by 87.4 points.
- GRDN has been more active in the news (17 items in the past 4 weeks vs 4 for YI).
- GRDN has more recent analyst coverage (6 ratings vs 0 for YI).
- Company
- Guardian Pharmacy Services Inc.
- 111 Inc.
- Price
- $39.47-0.48%
- $3.13-2.64%
- Market cap
- $2.51B
- $27.2M
- 1M return
- -12.50%
- -10.94%
- 1Y return
- +58.45%
- -28.91%
- Industry
- Retail-Drug Stores and Proprietary Stores
- Retail-Drug Stores and Proprietary Stores
- Exchange
- NYSE
- NASDAQ
- IPO
- 2024
- 2018
- News (4w)
- 17
- 4
- Recent ratings
- 6
- 0
111 Inc.
111, Inc. operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates through two segments, B2B and B2C. The company sells medical and wellness products through online retail, and wholesale and retail pharmacies, as well as provides value-added services, such as online consultation services and e-prescription services to consumers. Its product portfolio comprises prescription and over-the counter drugs, such as western and traditional Chinese medicinal drugs; nutritional supplements, such as vitamins and dietary products; contact lenses; medical supplies and devices, including bandages and thermometers; and personal care products, such as skin care, birth control, and sexual wellness products; and baby products. The company also operates an online marketplace where third-party sellers can directly sell to pharmacies; provides online loan application services to the clients of 1 Drug Mall, including pharmacies and wholesalers; and digital contract sales organization and data services. As of December 31, 2020, it operated 13 offline retail pharmacies under the Yi Hao Pharmacy brand name in Guangzhou, Wuhan, Tianjin, and Kunshan. In addition, the company offers warehousing, logistics, procurement, research and development, and consulting services; and software development and information technology support services. It serves pharmacies, pharmaceutical companies and distributors, medical professionals, and insurance companies. 111, Inc. has strategic partnerships with Bayer Healthcare Co. Ltd.; BeiGene, Ltd.; and Jianming Pharmaceutical Group. The company was formerly known as New Peak Group and changed its name to 111, Inc. in April 2018. 111, Inc. was founded in 2010 and is headquartered in Shanghai, the People's Republic of China.
Latest GRDN
- Officer Mudd William Franklin converted options into 38,282 shares, increasing direct ownership by 39% to 136,747 units (SEC Form 4)
- Officer Weir Robert converted options into 23,450 shares, increasing direct ownership by 29% to 103,333 units (SEC Form 4)
- Member of 10% Owner Group Ackerman John converted options into 1,884,996 shares (SEC Form 4)
- Member of 10% Owner Group Salentine Thomas J Jr converted options into 6,100,175 shares (SEC Form 4)
- Member of 10% Owner Group Burke Fred converted options into 1,298,825 shares, increasing direct ownership by 61% to 3,438,064 units (SEC Form 4)
- Member of 10% Owner Group Pharmacy Investors, Llc converted options into 1,413,939 shares, increasing direct ownership by 58% to 3,863,806 units (SEC Form 4)
- Officer Martin David Norman converted options into 39,865 shares, increasing direct ownership by 39% to 140,905 units (SEC Form 4)
- Officer Tuch Jeffrey converted options into 55,578 shares, increasing direct ownership by 32% to 231,847 units (SEC Form 4)
- Member of 10% Owner Group Forbes Kendall converted options into 608,570 shares, increasing direct ownership by 58% to 1,651,059 units (SEC Form 4)
- Member of 10% Owner Group Bindley William E converted options into 6,100,175 shares (SEC Form 4)
Latest YI
- Director Chen Yang Luke was granted 594,222 units of RSUs and sold $37,622 worth of RSUs (180,880 units at $0.21) (SEC Form 4) to cover taxes
- SEC Form 6-K filed by 111 Inc.
- 111, Inc. Announces Establishment of the Special Committee
- Director Chen Yang Luke sold $30,760 worth of RSUs (142,760 units at $0.22) and was granted 594,222 units of RSUs (SEC Form 4) (for tax liability)
- SEC Form 6-K filed by 111 Inc.
- SEC Form 6-K filed by 111 Inc.
- 111 Inc. Receives Unsolicited Preliminary Non-Binding Proposal to Acquire the Company
- 111, Inc. Announces Second Quarter 2026 Unaudited Financial Results
- Director Chen Yang Luke was granted 594,222 units of RSUs and sold $22,840 worth of RSUs (98,760 units at $0.23) (SEC Form 4) to cover withholding tax
- Director Sun Jian David was granted 810,271 units of RSUs and sold $92,749 worth of RSUs (397,060 units at $0.23) (SEC Form 4) (withholding tax)